<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">100967627</journal-id><journal-id journal-id-type="pubmed-jr-id">22283</journal-id><journal-id journal-id-type="nlm-ta">J Environ Sci (China)</journal-id><journal-id journal-id-type="iso-abbrev">J Environ Sci (China)</journal-id><journal-title-group><journal-title>Journal of environmental sciences (China)</journal-title></journal-title-group><issn pub-type="ppub">1001-0742</issn></journal-meta><article-meta><article-id pub-id-type="pmid">40246468</article-id><article-id pub-id-type="pmc">12006726</article-id><article-id pub-id-type="doi">10.1016/j.jes.2024.08.020</article-id><article-id pub-id-type="manuscript">HHSPA2020577</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Mixture analysis of associations between environmental and workplace toxins and liver damage and telomere length, stratified by race/ethnicity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Ning</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Yip</surname><given-names>Rowena</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Woodward</surname><given-names>Mark</given-names></name><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Lewis</surname><given-names>Sara</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Crane</surname><given-names>Michael</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Jirapatnakul</surname><given-names>Artit</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Aloman</surname><given-names>Costica</given-names></name><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Bansal</surname><given-names>Meena B.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Dieterich</surname><given-names>Douglas</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Gros</surname><given-names>Louis</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Valvi</surname><given-names>Damaskini</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Colicino</surname><given-names>Elena</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Yankelevitz</surname><given-names>David</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Henschke</surname><given-names>Claudia</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Branch</surname><given-names>Andrea D.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1.</label>Division of Liver Diseases, Icahn School of Medicine Mount Sinai, New York, NY, 10029, USA</aff><aff id="A2"><label>2.</label>Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA</aff><aff id="A3"><label>3.</label>The George Institute for Global Health, School of Public Health, Imperial College London, London, W12 7RZ, UK</aff><aff id="A4"><label>4.</label>The George Institute for Global Health, University of New South Wales, Sydney, 2000, Australia</aff><aff id="A5"><label>5.</label>Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA</aff><aff id="A6"><label>6.</label>Department of Medicine, Division of Gastroenterology and Hepatobiliary Diseases, Westchester Medical Center, Valhalla, 10595, USA</aff><author-notes><corresp id="CR1"><label>*</label>Corresponding author. <email>andrea.branch@mssm.edu</email> (A. D. Branch)</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>12</day><month>3</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>24</day><month>8</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>9</month><year>2026</year></pub-date><volume>155</volume><fpage>316</fpage><lpage>328</lpage><abstract id="ABS1"><p id="P1">This study aimed to identify the worst &#x0201c;bad actors&#x0201d; in mixtures of pollutants contributing to liver damage and shorter telomeres in the U.S. population, using Weighted Quantile Sum (WQS) modeling with stratification by race/ethnicity. We conducted a comprehensive cross-sectional analysis of mixtures of pollutants in National Health and Nutrition Examination Survey datasets: a) 33,979 adults with blood levels of cadmium (Cd), lead (Pb), and mercury, including subsets with measurements of per-/polyfluoroalkyl substances (PFAS), and polychlorinated biphenyls (PCBs)/polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs); and b) 7360 adults with measurements of telomeres, Cd, and Pb. Multivariable-adjusted WQS regression examined associations between WQS mixture indices and liver injury [alanine aminotransferase (ALT)-elevation], advanced liver-fibrosis (LF), and telomere length. WQS<sub>metal</sub> indices were associated with advanced-LF in all racial/ethnic groups. The top contributor was Cd in the total population and in non-Hispanic Whites (NHW), while Pb was the top contributor in non-Hispanic Blacks (NHB). The WQS<sub>metal-PCB-PCDD/F</sub> index was associated with ALT-elevation, with PCB126, Cd and Pb as main contributors; the odds ratio (OR) per decile was 1.50 (95%CI, 1.26&#x02013;1.78), while the OR per decile of the WQS<sub>metal-PFAS</sub> index was 1.03 (95%CI, 0.98&#x02013;1.05), not significant. WQS<sub>metal</sub> indices were associated with shorter telomeres. Cd was main contributor associated with advanced-LF in NHW, while Pb was the major bad actor in NHB, suggesting that NHB may be especially susceptible to Pb toxicity. Metals were associated with shorter telomeres. Metal and PCB/PCDD/F mixtures were associated with ALT-elevation. Heavy metals and organic chemicals may contribute to liver-related morbidity and healthcare disparities.</p></abstract><abstract abstract-type="graphical" id="ABS2"><title>Graphical Abstract</title><p id="P2">
<graphic xlink:href="nihms-2020577-f0006.jpg" position="anchor"/></p></abstract><kwd-group><kwd>Lead (Pb)</kwd><kwd>Cadmium (Cd)</kwd><kwd>Polychlorinated biphenyls</kwd><kwd>Mixture analysis</kwd><kwd>Liver injury</kwd><kwd>Racial disparities</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>Introduction</title><p id="P3">Liver disease claims over a million lives each year (<xref rid="R2" ref-type="bibr">Asrani et al., 2019</xref>). Many of these deaths could be prevented by reducing chronic liver injury. Environmental and workplace toxins, including heavy metals (cadmium (Cd); lead (Pb); and mercury (Hg)), polychlorinated biphenyls (PCBs) and other &#x0201c;forever chemicals&#x0201d;, are associated with liver injury (<xref rid="R9" ref-type="bibr">Cave et al., 2010</xref>; <xref rid="R39" ref-type="bibr">Tinkov et al., 2023</xref>), but additional data are needed to identify the most significant hepatotoxins and define the mechanisms of pathogenesis. It is likely that environmental exposures contribute to liver-related healthcare disparities. Heavy metals (Cd and Pb) are unevenly distributed geographically and are often higher in lower and middle-income countries (<xref rid="R24" ref-type="bibr">Levin et al., 2021</xref>; <xref rid="R36" ref-type="bibr">Sripada and Lager, 2022</xref>) and in communities of color (<xref rid="R8" ref-type="bibr">Cassidy-Bushrow et al., 2017</xref>). PCB concentrations are significantly higher in urban and industrial areas compared to rural areas (<xref rid="R29" ref-type="bibr">Othman et al., 2022</xref>). In the United States, African Americans have the higher blood levels of PCBs then Caucasians (<xref rid="R42" ref-type="bibr">Wesselink et al., 2019</xref>). However, additional data about specific exposures and vulnerabilities are needed for public health planning.</p><p id="P4">Most end-stage liver disease and liver-related mortality result from liver scarring (liver fibrosis (LF)), which can progress to cirrhosis, liver failure, and liver cancer (<xref rid="R10" ref-type="bibr">Dulai et al., 2017</xref>; <xref rid="R27" ref-type="bibr">Ng et al., 2023</xref>). Liver biopsy is the gold standard for diagnosing LF (<xref rid="R4" ref-type="bibr">Berger et al., 2019</xref>); but in population-level studies, LF and the risk of serious liver-related events are often estimated by using composite indices of non-invasive markers (<xref rid="R25" ref-type="bibr">Loomba and Adams, 2020</xref>), with or without a requirement for alanine aminotransferase (ALT) elevation. Composite fibrosis indices plus ALT elevation have area under the receiver operating characteristic curves (AUROCs) over 0.82 for identifying high risk individuals in community settings (<xref rid="R12" ref-type="bibr">Hagstr&#x000f6;m, et al., 2020</xref>). In this study, to maximize clinical relevance, we used a combination of composite fibrosis indices and ALT elevation to define our main endpoint, advanced-LF. We also examined associations between pollutants and ALT elevation, a widely-used clinical indicator of liver injury.</p><p id="P5">Toxic exposures have multiple injurious effects on cells. Environmental pollutants, including 1,4dioxane and benzidine (<xref rid="R28" ref-type="bibr">Niehoff et al., 2019</xref>) and heavy metals, Pb (<xref rid="R30" ref-type="bibr">Pawlas et al., 2015</xref>) and Cd (<xref rid="R43" ref-type="bibr">Xia et al., 2022</xref>), are associated with telomere shortening, which can reflect oxidative stress and chronic inflammation (<xref rid="R3" ref-type="bibr">Barnard et al., 2019</xref>). Shorter telomeres on peripheral blood mononuclear cells are associated with LF in patients with viral hepatitis (<xref rid="R16" ref-type="bibr">Hoare et al., 2010</xref>) and with LF (<xref rid="R21" ref-type="bibr">Kim et al., 2018</xref>) and increased mortality in people with steatotic (fatty) liver disease (<xref rid="R22" ref-type="bibr">Korkiakoski et al., 2022</xref>). Germline mutations in the telomerase pathway increase the risk of liver cirrhosis (<xref rid="R6" ref-type="bibr">Calado et al., 2011</xref>; <xref rid="R15" ref-type="bibr">Hartmann et al., 2011</xref>).</p><p id="P6">We (<xref rid="R26" ref-type="bibr">Ma et al., 2023</xref>) and others (<xref rid="R13" ref-type="bibr">Han et al., 2022</xref>), demonstrated that high (4<sup>th</sup> quartile) blood levels of Cd, a class I carcinogen (<xref rid="R1" ref-type="bibr">Alexander et al., 2009</xref>), are associated with fibrosis and other indicators of liver injury, consistent with data showing that Cd levels in urine are associated with liver-related outcomes (<xref rid="R17" ref-type="bibr">Hong et al., 2021</xref>; <xref rid="R18" ref-type="bibr">Hyder et al., 2013</xref>). We also found that high blood levels of Pb are associated with advanced-LF (&#x02265; F3) uniquely in non-Hispanic Black (NHB), and not in other racial/ethnic groups (<xref rid="R26" ref-type="bibr">Ma et al., 2023</xref>) and demonstrated that over 95% of U.S. adults with LF had PCB blood levels in the 4<sup>th</sup> quartile (<xref rid="R26" ref-type="bibr">Ma et al., 2023</xref>). These studies examined toxins individually, but real-world exposures typically involve multiple chemicals. Newly developed statistical techniques, such as weighted quantile sum (WQS) regression modeling, allow the components of mixtures to be examined collectively (<xref rid="R34" ref-type="bibr">Renzetti et al., 2019</xref>) and can identify the main &#x0201c;bad actors&#x0201d;. These methods reduce dimensionality and adjust for additive, synergistic and/or antagonistic effects among toxins (<xref rid="R34" ref-type="bibr">Renzetti et al., 2019</xref>).</p><p id="P7">The primary objective of this study was to use WQS modeling to analyze real-world exposures to pollutants and to identify the main contributors to advanced-LF and to liver injury (defined by ALT elevation) in the total population and in members of individual racial/ethnic groups. The secondary objectives were to determine the consistency of results of WQS and multivariable logistic regression (MVL) models and to analyze the relationships between toxic exposures and telomere length and between telomere length and advanced-LF. Toxins were selected based on data completeness and reported associations with liver disease.</p></sec><sec id="S2"><label>1</label><title>Methods</title><sec id="S3"><label>1.1</label><title>Study population and data sources</title><p id="P8">The mixture analyses were conducted in 33,979 adults (age &#x02265; 20 years) with blood levels of Cd, Pb and Hg in National Health and Nutrition Examination Survey (NHANES) 2003&#x02013;2018 as well as in three subsets with additional data: (1) 10,257 adults with data on four per- and polyfluoroalkyl substances (PFAS); (2) 12,847 adults with data on urine levels of eight metals; and (3) 1043 adults with data on 34 PCBs and six polychlorinated dibenzo-p-dioxins (PCDD) and dibenzofuranes (PCDF). Analyses of peripheral blood mononuclear cell telomere length and blood levels of Pb and Cd were conducted on 7360 adults with data in NHANES 1999&#x02013;2002 (<xref rid="F1" ref-type="fig">Fig. 1</xref>). Analysis of de-identified NHANES data is exempt from IRB review (<xref rid="R20" ref-type="bibr">Johnson et al., 2013</xref>).</p></sec><sec id="S4"><label>1.2</label><title>Definition of liver injury and fibrosis</title><p id="P9">Liver injury was defined as ALT elevation (&#x02265; 40 IU/L, men; &#x02265; 31 IU/L, women) (<xref rid="R26" ref-type="bibr">Ma et al., 2023</xref>). Advanced-LF was defined as ALT elevation and Fibrosis-4 (FIB-4) &#x02265; 2.67 and/or Forns Index &#x02265; 6.9 and/or Aspartate aminotransferase (AST) to Platelet Ratio Index (APRI) &#x02265; 1.5 (<xref rid="R12" ref-type="bibr">Hagstr&#x000f6;m et al., 2020</xref>).</p></sec><sec id="S5"><label>1.3</label><title>Covariates</title><p id="P10">The age range was 20&#x02013;85 years. Sex and race/ethnicity (non-Hispanic White (NHW), NHB, Mexican American (MA), and other race (O)) were self-reported. Smoking status, alcohol use, body mass index (BMI), poverty and diabetes were defined as before (<xref rid="R26" ref-type="bibr">Ma et al., 2023</xref>). Smoking categories were past/current and never. Alcohol use categories were lifetime abstainers, former drinkers, non-excessive current drinkers, and excessive current drinkers. BMI categories were normal weight (&#x0003c;25 kg/m<sup>2</sup>), overweight (25&#x02264; BMI &#x0003c;30 kg/m<sup>2</sup>), and obese (&#x02265;30 kg/m<sup>2</sup>). Diabetes was self-reported, and/or hemoglobin A1c &#x02265; 6.5%, and/or fasting plasma glucose &#x02265; 126 mg/dL. Poverty was a family poverty-income-ratio less than 1 (<xref rid="R26" ref-type="bibr">Ma et al., 2023</xref>). Viral hepatitis was past/current infection with hepatitis B virus (HBV), positive core antibody or surface antigen; or infection with hepatitis C virus (HCV), positive RNA or antibody (<xref rid="R26" ref-type="bibr">Ma et al., 2023</xref>). Blood levels of Pb, Cd, Hg, PFAS, and lipid-adjusted plasma levels of PCBs/PCCD/Fs and urine levels of eight heavy metals were analyzed as continuous (log-transformed) and binary variables (quartiles (Q)1&#x02013;3 versus Q4). Telomere length was determined by quantitative polymerase chain reaction (PCR) as described elsewhere (<xref rid="R33" ref-type="bibr">Rattan et al., 2022</xref>). Telomere length was categorized as quartiles.</p></sec><sec id="S6"><label>1.4</label><title>Statistical methods</title><p id="P11">Univariable and multivariable logistic (MVL) regression and WQS regression models were used to examine associations between exposures and outcomes. MVL models were used to assess the independent association of each compound with advanced-LF or ALT elevation, adjusting for covariates. The survey estimation commands for logistic regressions in SAS OnDemand for Academics (SAS Institute Inc., Cary, NC, USA) added sample weights, allowing the results to be extrapolated to the housed and non-institutionalized U.S. population. Age standardization estimates were obtained through the direct method and were standardized to the 2000 US census population. Differences between groups were assessed using t statistics.</p><p id="P12">The &#x0201c;gWQS&#x0201d; package in R (version 4.1.0) was used to evaluate the collective impact of toxic mixtures and to identify the primary drivers (<xref rid="R7" ref-type="bibr">Carrico et al., 2015</xref>). The dataset was randomly divided into training and validation sets (40% vs. 60%). In the training set, toxic component weights <inline-formula><mml:math id="M1" display="inline"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>w</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> were derived through 100X bootstrapping; weights ranged from 0 to 1 and summed to 1. The WQS index was then calculated by averaging the weights across the bootstrap sets and multiplying them by the toxic component&#x02019;s decile of concentration <inline-formula><mml:math id="M2" display="inline"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>:</mml:mo><mml:mi>W</mml:mi><mml:mi>Q</mml:mi><mml:mi>S</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mo>=</mml:mo><mml:mstyle displaystyle="true"><mml:msubsup><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>c</mml:mi></mml:msubsup><mml:mrow><mml:mover accent="true"><mml:mrow><mml:msub><mml:mi>w</mml:mi><mml:mi>l</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">&#x000af;</mml:mo></mml:mover><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mrow></mml:math></inline-formula>. Associations between the indices and liver endpoints were then evaluated in the validation set using WQS regression models. Sensitivity analysis was conducted by using Least Absolute Shrinkage and Selection Operator (Lasso) regression, a machine learning technique that encourages variables selection in model by adding a penalty term (<xref rid="R38" ref-type="bibr">Tibshirani et al., 1996</xref>). For dioxin-like PCBs and PCDD/Fs, a sensitivity analysis was conducted using Toxic Equivalent Quantity (TEQ) estimates. TEQs were calculated using the 2005 World Health Organization&#x02019;s toxic equivalency factors (TEFs) for dioxin-like compounds (<xref rid="R40" ref-type="bibr">Van den Berg et al., 2006</xref>). The TEQ for each specimen was determined by summing the products of the concentration of each congener and its corresponding TEF. Missing values of covariates (&#x0003c;10%) were addressed using multiple imputation by chained equations (<xref rid="R44" ref-type="bibr">Yuan, 2010</xref>). Statistical significance was a two-sided <italic toggle="yes">P</italic> value &#x0003c;0.05.</p></sec></sec><sec id="S7"><label>2</label><title>Results</title><sec id="S8"><label>2.1</label><title>Study group</title><p id="P13">NHANES provides cross-sectional data about the residential population of the United States. In this study we analyzed data on NHANES participants with the following data: 1) blood levels of Pb, Cd and Hg (<italic toggle="yes">n</italic> = 33,979); 2) blood levels of Pb, Cd, Hg and four PFAS (<italic toggle="yes">n</italic> = 10,257); 3) urine levels of eight metals (Pb, Cd, barium, cesium, cobalt, antimony, thallium, tungsten) and blood levels of Pb, Cd, and Hg (<italic toggle="yes">n</italic> = 12,847); 4) blood levels of Pb, Cd, Hg, 34 PCBs and six PCDD/Fs (<italic toggle="yes">n</italic> = 1043); 5) blood levels of Pb and Cd and telomere length (<italic toggle="yes">n</italic> = 7360) (<xref rid="F1" ref-type="fig">Fig. 1</xref>). The characteristics of the NHANES participants with data about the various toxins and telomere length are presented in <xref rid="SD1" ref-type="supplementary-material">Appendix A Tables S1a</xref>&#x02013;<xref rid="SD1" ref-type="supplementary-material">S1e</xref>.</p></sec><sec id="S9"><label>2.2</label><title>Blood levels of heavy metals and MVL analysis of risk factors for advanced-LF and ALT elevation</title><p id="P14">Among NHB, high (Q4 vs Q1&#x02013;3) blood levels of Pb were associated with advanced-LF in an MVL model that adjusted for the survey cycle, age, sex, BMI, smoking status, alcohol use, diabetes, and poverty. The odds ratio (OR) for high (Q4 vs Q1&#x02013;3) Pb was 2.26 (95%CI, 1.37&#x02013;3.74) (<xref rid="T1" ref-type="table">Table 1</xref>). NHB persons were both more likely to have high blood levels of Pb (<xref rid="F2" ref-type="fig">Fig. 2</xref>) and they had a higher risk of advanced-LF when exposed to high Pb than NHW or any other racial/ethnic group (<xref rid="T1" ref-type="table">Table 1</xref>). In an analysis that excluded participants with viral hepatitis exposure, high Pb remained associated with advanced-LF in NHB (OR = 2.39; 95%CI, 1.18&#x02013;4.86) (<xref rid="SD1" ref-type="supplementary-material">Appendix A Table S2</xref>). When analyzed as a continuous variable, Pb was associated with advanced-LF in NHB in a dose-dependent manner (<xref rid="SD1" ref-type="supplementary-material">Appendix A Table S3</xref>), but Pb was not associated with advanced-LF in any other racial/ethnic group, whether when analyzed as a categorical or continuous variable (<xref rid="T1" ref-type="table">Table 1</xref> and <xref rid="SD1" ref-type="supplementary-material">Appendix A Tables S2</xref> and <xref rid="SD1" ref-type="supplementary-material">S3</xref>). In contrast to high Pb, high Cd was associated with advanced-LF in the total population and in all racial/ethnic groups, with ORs ranging from 1.73&#x02013;2.19. Hg was not associated with advanced-LF in any group. Diabetes was associated with advanced-LF in the total population and in NHW, MA and O, but not in NHB (OR = 0.73; 95%CI, 0.46&#x02013;1.17), underscoring the distinctiveness of the factors associated with advanced-LF in NHB (<xref rid="T1" ref-type="table">Table 1</xref>).</p><p id="P15">In an investigation of factors associated with ALT elevation, high Pb (Q4 vs Q1&#x02013;3) had an OR of 1.24 (95% CI, 1.01&#x02013;1.53) and high Cd had an OR of 1.25 (95% CI, 1.03&#x02013;1.55) in NHB. Neither high Pb nor high Cd was significantly associated with ALT elevation in any other group. Q4 blood levels of Hg were associated with ALT elevation in the total population and in MA (<xref rid="SD1" ref-type="supplementary-material">Appendix A Table S4</xref>).</p></sec><sec id="S10"><label>2.3</label><title>WQS analysis of blood levels of metals and liver endpoints</title><p id="P16">Spearman correlations between Pb and Cd ranged up to 0.4 (<xref rid="SD1" ref-type="supplementary-material">Appendix A Fig. S1</xref>); thus, WQS modeling was used to identify the true &#x0201c;bad actors&#x0201d; (<xref rid="R7" ref-type="bibr">Carrico et al., 2015</xref>). WQS<sub>metal</sub> indices were determined for all group 1 participants (<italic toggle="yes">n</italic> = 33,979) and for each racial/ethnic group. The indices were significantly associated with advanced-LF in the total population and in NHW, NHB, and MA in models that adjusted for age, sex, smoking status, alcohol use, BMI, poverty, and diabetes. ORs ranged from 1.12 (95% CI, 1.01&#x02013;1.24) per decile of the WQS<sub>metal</sub> index in MA to 1.40 (95% CI, 1.21&#x02013;1.64) in NHB (<xref rid="F3" ref-type="fig">Fig. 3</xref>). Pb was the most significant contributor in NHB, while Cd was the most significant contributor in the total population and in the other racial/ethnic groups (<xref rid="F3" ref-type="fig">Fig. 3</xref>). Among NHB, the OR of advanced-LF for participants in the top decile of the WQS<sub>metal</sub> index was 20.7 (95% CI, 5.6&#x02013;85.8) (<xref rid="F3" ref-type="fig">Fig. 3</xref>). In other analyses, the WQS<sub>metal</sub> indices were significantly associated with ALT elevation in the total population, NHW, NHB and MA. Pb was the major contributor in NHB and MA, while Hg and Pb were the top contributors in the total population (<xref rid="SD1" ref-type="supplementary-material">Appendix A Table S5</xref>).</p></sec><sec id="S11"><label>2.4</label><title>WQS analysis of metal-PFAS indices and liver endpoints</title><p id="P17">Spearman correlations between blood levels of metals and PFAS are shown in <xref rid="SD1" ref-type="supplementary-material">Appendix A Fig. S2</xref>. In group 2 participants (<italic toggle="yes">n</italic> = 10,257), the WQS<sub>metal</sub> index was significantly associated with advanced-LF (OR = 1.17 (95% CI, 1.03&#x02013;1.32)) and ALT elevation (OR = 1.03 (95% CI, 1.00&#x02013;1.07)), after adjusting with age, sex, smoking status, alcohol use, poverty and diabetes, consistent with results in group 1, while the WQS<sub>PFAS</sub> index was not associated with either advanced-LF or ALT elevation (<xref rid="SD1" ref-type="supplementary-material">Appendix A Figs. S3</xref>&#x02013;<xref rid="SD1" ref-type="supplementary-material">S4</xref>). The OR of the WQS<sub>metal-PFAS</sub> index was similar to that of the WQS<sub>metal</sub> index for the association with advanced-LF; Cd was the major contributor (<xref rid="SD1" ref-type="supplementary-material">Appendix A Fig. S4</xref>). Sample size limitations precluded stratification by race/ethnicity with outcome of advanced-LF. Neither the WQS<sub>metal-PFAS</sub> index nor the WQS<sub>PFAS</sub> index was associated with ALT elevation in most racial/ethnic groups (<xref rid="SD1" ref-type="supplementary-material">Appendix A Figs. S5</xref> and <xref rid="SD1" ref-type="supplementary-material">S6</xref>, respectively).</p></sec><sec id="S12"><label>2.5</label><title>WQS analysis of blood and urine metals and liver endpoints</title><p id="P18">Spearman correlations among heavy metals in blood and urine are shown in <xref rid="SD1" ref-type="supplementary-material">Appendix A Fig. S7</xref>. In group 3 participants (<italic toggle="yes">n</italic> = 12,847), the WQS indices of heavy metals in a) blood, b) urine, and c) blood and urine were all significantly associated with both advanced-LF and ALT elevation. The index of the combination of blood and urine metals had the highest adjusted ORs: 1.15 (95% CI: 1.03&#x02013;1.29) for advanced-LF and 1.06 (95% CI: 1.02&#x02013;1.10) for ALT elevation; blood and urine Cd were the major contributors (<xref rid="SD1" ref-type="supplementary-material">Appendix A Figs. S8</xref> and <xref rid="SD1" ref-type="supplementary-material">S9</xref>). Sample size limitations precluded stratification by race/ethnicity with outcome of advanced-LF. The indices were not associated with ALT elevation in most individual racial/ethnic groups (<xref rid="SD1" ref-type="supplementary-material">Appendix A Figs. S10</xref> and <xref rid="SD1" ref-type="supplementary-material">S11</xref>).</p></sec><sec id="S13"><label>2.6</label><title>WQS analysis of PCBs, PCDD/Fs, metals in blood and ALT elevation</title><p id="P19">Before conducting a mixture analysis, 34 PCBs, six PCDD/Fs and three heavy metals (Pb, Cd, and Hg) were analyzed individually for associations with ALT elevation in the total group (group 4, <italic toggle="yes">n</italic> = 1043) with adjustment for age, sex, and race/ethnicity (<xref rid="SD1" ref-type="supplementary-material">Appendix A Table S6</xref>). PCB209 was excluded from the subsequent mixture analysis because its concentration is inversely related to ALT elevation. Spearman correlations among the remaining pollutants are shown in <xref rid="SD1" ref-type="supplementary-material">Appendix A Fig. S12</xref>. The WQS<sub>metal-PCB-PCDD/F</sub> index was significantly associated with ALT elevation in the total population of group 4: OR = 1.50 per decile (95% CI, 1.26&#x02013;1.78), reaching an OR of 38.4 (95% CI, 8.0&#x02013;179.0) in the top decile, after adjusting for age, sex, and race/ethnicity. PCB126, Cd, Pb, PCB101, PCB172, Hg and 1,2,3,4,6,7,8-heptachlororodibenzo-p-dioxin (HpCDD) were the primary contributors. PCB126 had the highest weight by far (<xref rid="F4" ref-type="fig">Fig. 4</xref>). Sample size limitations precluded analysis with outcome of advanced-LF.</p><p id="P20">In a comparison of ORs for the associations between ALT elevations and WQS indices in groups 2 and 4, the WQS<sub>metal-PCB-PCDD/F</sub> index had the highest value, followed by the WQS<sub>PCB-PCDD/F</sub> index. The ORs of the indices for mixtures that included PCBs/PCDD/Fs were higher than those that included PFAS (<xref rid="F4" ref-type="fig">Fig. 4</xref>), after adjusting for age, sex, and race/ethnicity. These results underscore the importance of heavy metals and selected persistent organic pollutants as potential drivers of liver injury.</p><p id="P21">An additional WQS analysis of the metal-PCB-PCDD/F mixture was carried out because many pairs of PCBs have correlation coefficients exceeding 0.7 (<xref rid="SD1" ref-type="supplementary-material">Appendix A Fig. S12</xref>). In this case, components with weights over 0.005 may be significant contributors (<xref rid="R7" ref-type="bibr">Carrico et al., 2015</xref>). Several additional compounds are above this threshold and might be considered significant contributors (<xref rid="F4" ref-type="fig">Fig. 4</xref>). Lasso regression modeling was used as an additional alternative approach for identifying chemicals positively associated with ALT elevation. In general agreement with the WQS<sub>metal-PCB-PCDD/F</sub> index, PCB126, PCB172, HpCDD, Cd, and Hg were selected, in addition to PCB151, PCB105, and octachlorodibenzo-<italic toggle="yes">p</italic>-dioxin (OCDD) (<xref rid="SD1" ref-type="supplementary-material">Appendix A Table S7</xref>).</p><p id="P22">In the TEQ analysis of dioxin-like PCBs and PCDD/Fs, the association between ALT elevation and the TEQ values of PCB 105, 118, 126, HpCDD, and OCDD was highly significant (OR = 1.89 (95% CI, 1.09&#x02013;3.26) per 10 pg/g TEQ) when the TEQ values were treated as a continuous variable, after adjusting for age, sex, and race/ethnicity. The association was also highly significant when the TEQ values were treated as a categorical variable. Compared to participants with TEQ values in Q1, those in Q3 and Q4 had ORs of 3.43 (95% CI, 1.80&#x02013;6.56) and 3.21 (95% CI, 1.90&#x02013;5.41), respectively, after adjusting for age, sex, and race/ethnicity (<xref rid="SD1" ref-type="supplementary-material">Appendix A Table S8</xref>). Notably, PCB 105, 118, 126, HpCDD, and OCDD were significantly associated with ALT elevation in both the single-chemical analysis (<xref rid="SD1" ref-type="supplementary-material">Appendix A Table S6</xref>) and in the WQS mixture analysis (<xref rid="F4" ref-type="fig">Fig. 4</xref>), indicating that these compounds are major contributors to liver disease risk, aligning with our primary findings. An analysis that included all of the dioxin-like PCBs and PCDD/Fs in our dataset that have reported TEQ values did not show a significant association with ALT elevation (<xref rid="SD1" ref-type="supplementary-material">Appendix A Table S9</xref>).</p></sec><sec id="S14"><label>2.7</label><title>Racial/ethnic disparities in toxin levels</title><p id="P23">NHB had higher blood levels of liver toxicants than NHW, as indicated by their higher age-standardized weighted mean blood levels of Pb, Cd, PCB126, PCB172, HpCDD, and OCDD (<xref rid="F2" ref-type="fig">Fig. 2</xref>).</p></sec><sec id="S15"><label>2.8</label><title>Blood levels of Pb, Cd, and telomere length</title><p id="P24">NHANES 1999&#x02013;2002 included 7360 adults with measurements of both blood levels of Pb and Cd and blood cell telomere length (<xref rid="F1" ref-type="fig">Fig. 1</xref> and <xref rid="SD1" ref-type="supplementary-material">Appendix A Table S1e</xref>). In an MVL model, telomere length had an inverse relationship with advanced-LF. Compared to Q4, the adjusted ORs for Q3 to Q1 varied from 4.31 to 5.28, indicating a higher risk of advanced-LF with decreasing telomere length (<xref rid="F5" ref-type="fig">Fig. 5a</xref>). Sample size limitations precluded stratification by race/ethnicity. Telomere length was not significantly associated with ALT elevation (<xref rid="SD1" ref-type="supplementary-material">Appendix A Fig. S13</xref>). Heavy metals were associated with short (Q1) telomere length in WQS models in the total population, OR=1.12 (95%CI 1.08, 1.17) and in NHW and NHB; Cd was the top contributor (<xref rid="F5" ref-type="fig">Fig. 5b</xref>).</p></sec></sec><sec id="S16"><label>3</label><title>Discussion</title><p id="P25">In this comprehensive cross-sectional study, we investigated associations between toxin levels in prospectively-collected specimens and liver scarring (advanced-LF) and liver injury (ALT elevation) in adults in the United States. We analyzed 53 toxins with blood and/or urine levels measured in NHANES. Four findings have public health importance.</p><p id="P26">First, Pb exposure was associated with advanced-LF in both MVL and WQS models in NHB and in no other racial/ethnic group. The high ORs and their concordance suggest that NHB may have a heightened vulnerability to the hepatotoxic effects of Pb, but additional research is needed to examine the possibility that Pb is a proxy for other exposures. NHB have a high frequency of a variant of the arylsulfatase A gene (<xref rid="R37" ref-type="bibr">Taylor et al., 2016</xref>) that increases susceptibility to Pb toxicity in cultured cells (<xref rid="R31" ref-type="bibr">Poretz et al., 2000</xref>). This, or other genetic factors, could contribute to the unique risk profile of NHBs for advanced-LF, which included high Pb levels but did not include diabetes in this study or in prior studies (<xref rid="R5" ref-type="bibr">Browning et al., 2018</xref>; <xref rid="R26" ref-type="bibr">Ma et al., 2023</xref>). Heightened susceptibility to toxins may extend beyond Pb, as indicated by data showing that NHB who smoke develop lung cancer at a younger age and with fewer pack-years of smoking than NHW (<xref rid="R32" ref-type="bibr">Prosper et al., 2020</xref>).</p><p id="P27">Second, blood levels of many hepatotoxins were higher in NHB than in NHW, consistent with published findings (<xref rid="R26" ref-type="bibr">Ma et al., 2023</xref>). These results identify a potential source of liver-related healthcare disparities that could be addressed through public health measures. The higher blood levels of toxins in NHB could reflect greater exposure, greater intake, greater absorption, or greater retention in the body.</p><p id="P28">Third, WQS models confirmed the importance of Cd toxicity in the total population and in major subgroups. In WQS models, both urine and blood levels of Cd were associated with advanced-LF and ALT elevation and blood levels of Cd were also associated with shorter telomeres.</p><p id="P29">Fourth, the group of persistent organic pollutants that include PCBs and PCDD/Fs had a much higher OR for ALT elevation than PFAS (1.31 vs. 1.02), establishing the importance of reducing levels of PCBs and structurally-related compounds, even as the important efforts to reduce PFAS are carried out. Although PCB manufacturing was banned in the United States in 1979, production continued in other parts of the world until 2001. A recent study identified 149 different PCBs that can be derived from commercial products still being manufactured (<xref rid="R14" ref-type="bibr">Hannah et al., 2022</xref>). Once created, PCBs can persist in the environment for long periods (<xref rid="R41" ref-type="bibr">van den Berg et al., 2017</xref>).</p><p id="P30">PCB126 was the most significant contributor to ALT elevation in WQS models that included PCBs and PCDD/Fs, highlighting the importance of this potent dioxin-like toxicant. PCB126 was only a minor constituent of commercial PCB products (<xref rid="R11" ref-type="bibr">Frame et al., 1996</xref>), but it contributed 37&#x02013;59% of the liver toxic equivalents (<xref rid="R19" ref-type="bibr">Iwata et al., 2004</xref>). PCB126 was classified as group 1 carcinogen by the International Agency for Research on Cancer (<xref rid="R23" ref-type="bibr">Lauby-Secretan et al., 2016</xref>). It is a high affinity ligand of the aryl hydrocarbon receptor (AhR). Activation of AhR by PCB126 results in liver steatosis and altered metabolism (<xref rid="R35" ref-type="bibr">Shen et al., 2019</xref>; <xref rid="R45" ref-type="bibr">Zhang et al., 2012</xref>).</p></sec><sec id="S17"><label>4</label><title>Strengths and limitations</title><p id="P31">The strengths include the use of: (1) clinically-meaningful endpoints to evaluate hepatotoxic effects, (2) nationally representative NHANES data, (3) two complementary statistical approaches, WQS and MVL modeling, and d) stratification by race/ethnicity. Limitations include: (1) the lack of biopsy data to confirm fibrosis stage, which we mitigated by analyzing both ALT elevation and well-validated composite indices of advanced-LF, (2) sample size limitations that precluded stratification by race/ethnicity in several cases, (3) the inability to directly compare certain exposures because toxicants were measured in non-overlapping groups, and (4) the cross-sectional design of NHANES, which precludes an investigation of causality, (5) The WQS method is sensitive to collinearity among components, which can affect the stability and interpretability of the weights assigned to each component. For the highly correlated PCB/PCDD/Fs data, we mitigated this by using lower weight cutoffs for significant components and by conducting sensitivity analyses using Lasso Regression and TEQ mixture analysis to confirm the primary results.</p></sec><sec id="S18"><label>5</label><title>Conclusions</title><p id="P32">WQS analysis of common pollutants revealed that metal mixture indices are significantly associated with liver damage and shorter telomeres. Pb is the main contributor of the mixture indices associated with advanced-LF and ALT elevation in NHB and with ALT elevation in MA. Cd was the main contributor to the associations between the mixture indices and advanced-LF and shorter telomere length in the total population. Several PCBs and dioxin-like compounds, most notably PCB126, are the primary contributors to the association between the mixture indices and liver injury. The results suggest that African Americans may be especially susceptible to the toxic effect of Pb. Future safety regulations may need to be adjusted to ensure that standards protect people with heightened vulnerability. The results highlight the opportunity to reduce the burden of liver disease by reducing exposure to environmental pollutants.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>1</label><media xlink:href="NIHMS2020577-supplement-1.docx" id="d67e802" position="anchor"/></supplementary-material></sec></body><back><ack id="S19"><title>Acknowledgments</title><p id="P33">The research was supported by U01OH012263, and U01 OH012622 from the National Institute for Occupational Safety and Health; PCF 604934 from Prevent Cancer Foundation; National Institutes of Health (NIH)/ National Cancer Institute (NCI) 1U01CA288425&#x02013;0; and P30 ES023515 from the National Institute of Environmental Health Sciences.</p></ack><fn-group><fn fn-type="COI-statement" id="FN1"><p id="P34">Declaration of Competing Interest</p><p id="P35">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></fn><fn id="FN2"><p id="P36">Appendix A Supplementary data</p><p id="P37">Supplementary data associated with this article can be found in the online version.</p></fn><fn id="FN3"><p id="P38" content-type="publisher-disclaimer">This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><mixed-citation publication-type="journal"><name><surname>Alexander</surname><given-names>J</given-names></name>, <name><surname>Benford</surname><given-names>D</given-names></name>, <name><surname>Cockburn</surname><given-names>A</given-names></name>, <name><surname>Cravedi</surname><given-names>JP</given-names></name>, <name><surname>Dogliotti</surname><given-names>E</given-names></name>, <name><surname>Di Domenico</surname><given-names>A</given-names></name>, <etal/>, <year>2009</year>. <article-title>SCIENTIFIC OPINION cadmium in food scientific opinion of the panel on contaminants in the food chain</article-title>. <source>EFSA J</source>. <volume>980</volume> (<issue>1</issue>), <fpage>139</fpage>.</mixed-citation></ref><ref id="R2"><mixed-citation publication-type="journal"><name><surname>Asrani</surname><given-names>SK</given-names></name>, <name><surname>Devarbhavi</surname><given-names>H</given-names></name>, <name><surname>Eaton</surname><given-names>J</given-names></name>, <name><surname>Kamath</surname><given-names>PS</given-names></name>,<year>2019</year>. <article-title>Burden of liver diseases in the world</article-title>. <source>J. Hepatol</source>. <volume>70</volume> (<issue>1</issue>), <fpage>151</fpage>&#x02013;<lpage>171</lpage>.<pub-id pub-id-type="pmid">30266282</pub-id>
</mixed-citation></ref><ref id="R3"><mixed-citation publication-type="journal"><name><surname>Barnard</surname><given-names>A</given-names></name>, <name><surname>Moch</surname><given-names>A</given-names></name>, <name><surname>Saab</surname><given-names>S</given-names></name>, <year>2019</year>. <article-title>Relationship between telomere maintenance and liver disease</article-title>. <source>Gut. Liver</source>. <volume>13</volume> (<issue>1</issue>), <fpage>11</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">30400735</pub-id>
</mixed-citation></ref><ref id="R4"><mixed-citation publication-type="journal"><name><surname>Berger</surname><given-names>D</given-names></name>, <name><surname>Desai</surname><given-names>V</given-names></name>, <name><surname>Janardhan</surname><given-names>S</given-names></name>, <year>2019</year>. <article-title>Con: Liver biopsy remains the gold standard to evaluate fibrosis in patients with nonalcoholic fatty liver disease</article-title>. <source>Clin. Liver Dis. (Hoboken)</source>
<volume>13</volume> (<issue>4</issue>), <fpage>114</fpage>&#x02013;<lpage>116</lpage>.<pub-id pub-id-type="pmid">31061705</pub-id>
</mixed-citation></ref><ref id="R5"><mixed-citation publication-type="journal"><name><surname>Browning</surname><given-names>MG</given-names></name>, <name><surname>Khoraki</surname><given-names>J</given-names></name>, <name><surname>DeAntonio</surname><given-names>JH</given-names></name>, <name><surname>Mazzini</surname><given-names>G</given-names></name>, <name><surname>Mangino</surname><given-names>MJ</given-names></name>, <name><surname>Siddiqui</surname><given-names>MS</given-names></name>, <etal/>, <year>2018</year>. <article-title>Protective effect of black relative to white race against non-alcoholic fatty liver disease in patients with severe obesity, independent of type 2 diabetes</article-title>. <source>Int. J. Obes. (Lond)</source>
<volume>42</volume> (<issue>4</issue>), <fpage>926</fpage>&#x02013;<lpage>929</lpage>.<pub-id pub-id-type="pmid">29437160</pub-id>
</mixed-citation></ref><ref id="R6"><mixed-citation publication-type="journal"><name><surname>Calado</surname><given-names>RT</given-names></name>, <name><surname>Brudno</surname><given-names>J</given-names></name>, <name><surname>Mehta</surname><given-names>P</given-names></name>, <name><surname>Kovacs</surname><given-names>JJ</given-names></name>, <name><surname>Wu</surname><given-names>C</given-names></name>, <name><surname>Zago</surname><given-names>MA</given-names></name>, <etal/>, <year>2011</year>. <article-title>Constitutional telomerase mutations are genetic risk factors for cirrhosis</article-title>. <source>Hepatology</source>
<volume>53</volume> (<issue>5</issue>), <fpage>1600</fpage>&#x02013;<lpage>1607</lpage>.<pub-id pub-id-type="pmid">21520173</pub-id>
</mixed-citation></ref><ref id="R7"><mixed-citation publication-type="journal"><name><surname>Carrico</surname><given-names>C</given-names></name>, <name><surname>Gennings</surname><given-names>C</given-names></name>, <name><surname>Wheeler</surname><given-names>DC</given-names></name>, <name><surname>Factor-Litvak</surname><given-names>P</given-names></name>, <year>2015</year>. <article-title>Characterization of weighted quantile sum regression for highly correlated data in a risk analysis setting</article-title>. <source>J. Agric. Biol. Environ. Stat</source>. <volume>20</volume> (<issue>1</issue>), <fpage>100</fpage>&#x02013;<lpage>120</lpage>.<pub-id pub-id-type="pmid">30505142</pub-id>
</mixed-citation></ref><ref id="R8"><mixed-citation publication-type="journal"><name><surname>Cassidy-Bushrow</surname><given-names>AE</given-names></name>, <name><surname>Sitarik</surname><given-names>AR</given-names></name>, <name><surname>Havstad</surname><given-names>S</given-names></name>, <name><surname>Park</surname><given-names>SK</given-names></name>, <name><surname>Bielak</surname><given-names>LF</given-names></name>, <name><surname>Austin</surname><given-names>C</given-names></name>, <etal/>, <year>2017</year>. <article-title>Burden of higher lead exposure in African-Americans starts in utero and persists into childhood</article-title>. <source>Environ. Int</source>. <volume>108</volume>, <fpage>221</fpage>&#x02013;<lpage>227</lpage>.<pub-id pub-id-type="pmid">28886415</pub-id>
</mixed-citation></ref><ref id="R9"><mixed-citation publication-type="journal"><name><surname>Cave</surname><given-names>M</given-names></name>, <name><surname>Appana</surname><given-names>S</given-names></name>, <name><surname>Patel</surname><given-names>M</given-names></name>, <name><surname>Falkner</surname><given-names>KC</given-names></name>, <name><surname>McClain</surname><given-names>CJ</given-names></name>, <name><surname>Brock</surname><given-names>G</given-names></name>, <year>2010</year>. <article-title>Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003&#x02013;2004</article-title>. <source>Environ. health Persp</source>. <volume>118</volume> (<issue>12</issue>), <fpage>1735</fpage>&#x02013;<lpage>1742</lpage>.</mixed-citation></ref><ref id="R10"><mixed-citation publication-type="journal"><name><surname>Dulai</surname><given-names>PS</given-names></name>, <name><surname>Singh</surname><given-names>S</given-names></name>, <name><surname>Patel</surname><given-names>J</given-names></name>, <name><surname>Soni</surname><given-names>M</given-names></name>, <name><surname>Prokop</surname><given-names>LJ</given-names></name>, <name><surname>Younossi</surname><given-names>Z</given-names></name>, <etal/>, <year>2017</year>. <article-title>Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis</article-title>. <source>Hepatology</source>
<volume>65</volume> (<issue>5</issue>), <fpage>1557</fpage>&#x02013;<lpage>1565</lpage>.<pub-id pub-id-type="pmid">28130788</pub-id>
</mixed-citation></ref><ref id="R11"><mixed-citation publication-type="journal"><name><surname>Frame</surname><given-names>GM</given-names></name>, <name><surname>Cochran</surname><given-names>JW</given-names></name>, <name><surname>B&#x000f8;wadt</surname><given-names>S</given-names></name>, <etal/>, <year>1996</year>. <article-title>Complete PCB congener distributions for 17 Aroclor mixtures determined by 3 HRGC systems optimized for comprehensive, quantitative, congener&#x02010;specific analysis</article-title>. <source>J. High Resol. Chromatogr</source>. <volume>19</volume> (<issue>12</issue>), <fpage>657</fpage>&#x02013;<lpage>668</lpage>.</mixed-citation></ref><ref id="R12"><mixed-citation publication-type="journal"><name><surname>Hagstr&#x000f6;m</surname><given-names>H</given-names></name>, <name><surname>Talb&#x000e4;ck</surname><given-names>M</given-names></name>, <name><surname>Andreasson</surname><given-names>A</given-names></name>, <name><surname>Walldius</surname><given-names>G</given-names></name>, <name><surname>Hammar</surname><given-names>N</given-names></name>, <year>2020</year>. <article-title>Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease</article-title>. <source>Gastroenterology</source>
<volume>158</volume> (<issue>1</issue>), <fpage>200</fpage>&#x02013;<lpage>214</lpage>.<pub-id pub-id-type="pmid">31563624</pub-id>
</mixed-citation></ref><ref id="R13"><mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>S</given-names></name>, <name><surname>Sung</surname><given-names>GH</given-names></name>, <name><surname>Lee</surname><given-names>S</given-names></name>, <name><surname>Han</surname><given-names>KJ</given-names></name>, <name><surname>Han</surname><given-names>HJ</given-names></name>, <year>2022</year>. <article-title>Serum cadmium is associated with hepatic steatosis and fibrosis: Korean national health and nutrition examination survey data IV-VII</article-title>. <source>Medicine (Baltimore)</source>
<volume>101</volume> (<issue>4</issue>), e28559.</mixed-citation></ref><ref id="R14"><mixed-citation publication-type="journal"><name><surname>Hannah</surname><given-names>TJ</given-names></name>, <name><surname>Megson</surname><given-names>D</given-names></name>, <name><surname>Sandau</surname><given-names>CD</given-names></name>, <year>2022</year>. <article-title>A review of the mechanisms of by-product PCB formation in pigments, dyes and paints</article-title>. <source>Sci. Total. Environ</source>. <volume>852</volume>, 158529.</mixed-citation></ref><ref id="R15"><mixed-citation publication-type="journal"><name><surname>Hartmann</surname><given-names>D</given-names></name>, <name><surname>Srivastava</surname><given-names>U</given-names></name>, <name><surname>Thaler</surname><given-names>M</given-names></name>, <name><surname>Kleinhans</surname><given-names>KN</given-names></name>, <name><surname>N&#x02019;Kontchou</surname><given-names>G</given-names></name>, <name><surname>Scheffold</surname><given-names>A</given-names></name>, <etal/>, <year>2011</year>. <article-title>Telomerase gene mutations are associated with cirrhosis formation</article-title>. <source>Hepatology</source>
<volume>53</volume> (<issue>5</issue>), <fpage>1608</fpage>&#x02013;<lpage>1617</lpage>.<pub-id pub-id-type="pmid">21520174</pub-id>
</mixed-citation></ref><ref id="R16"><mixed-citation publication-type="journal"><name><surname>Hoare</surname><given-names>M</given-names></name>, <name><surname>Gelson</surname><given-names>WT</given-names></name>, <name><surname>Das</surname><given-names>A</given-names></name>, <name><surname>Fletcher</surname><given-names>JM</given-names></name>, <name><surname>Davies</surname><given-names>SE</given-names></name>, <name><surname>Curran</surname><given-names>MD</given-names></name>, <etal/>, <year>2010</year>. <article-title>CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection</article-title>. <source>J. Hepatol</source>. <volume>53</volume> (<issue>2</issue>), <fpage>252</fpage>&#x02013;<lpage>260</lpage>.<pub-id pub-id-type="pmid">20462651</pub-id>
</mixed-citation></ref><ref id="R17"><mixed-citation publication-type="journal"><name><surname>Hong</surname><given-names>D</given-names></name>, <name><surname>Min</surname><given-names>JY</given-names></name>, <name><surname>Min</surname><given-names>KB</given-names></name>, <year>2021</year>. <article-title>Association between cadmium exposure and liver function in adults in the United States: a cross-sectional study</article-title>. <source>J. Prev. Med. Public Health</source>
<volume>54</volume> (<issue>6</issue>), <fpage>471</fpage>.<pub-id pub-id-type="pmid">34875830</pub-id>
</mixed-citation></ref><ref id="R18"><mixed-citation publication-type="journal"><name><surname>Hyder</surname><given-names>O</given-names></name>, <name><surname>Chung</surname><given-names>M</given-names></name>, <name><surname>Cosgrove</surname><given-names>D</given-names></name>, <name><surname>Herman</surname><given-names>JM</given-names></name>, <name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Firoozmand</surname><given-names>A</given-names></name>, <etal/>, <year>2013</year>. <article-title>Cadmium exposure and liver disease among US adults</article-title>. <source>J. Gastrointest. Surg</source>. <volume>17</volume>, <fpage>1265</fpage>&#x02013;<lpage>1273</lpage>.<pub-id pub-id-type="pmid">23636881</pub-id>
</mixed-citation></ref><ref id="R19"><mixed-citation publication-type="journal"><name><surname>Iwata</surname><given-names>H</given-names></name>, <name><surname>Watanabe</surname><given-names>M</given-names></name>, <name><surname>Okajima</surname><given-names>Y</given-names></name>, <name><surname>Tanabe</surname><given-names>S</given-names></name>, <name><surname>Amano</surname><given-names>M</given-names></name>, <name><surname>Miyazaki</surname><given-names>N</given-names></name>, <etal/>, <year>2004</year>. <article-title>Toxicokinetics of PCDD, PCDF, and coplanar PCB congeners in Baikal seals, Pusa sibirica: age-related accumulation, maternal transfer, and hepatic sequestration</article-title>. <source>Environ. Sci. Technol</source>. <volume>38</volume> (<issue>13</issue>), <fpage>3505</fpage>&#x02013;<lpage>3513</lpage>.<pub-id pub-id-type="pmid">15296299</pub-id>
</mixed-citation></ref><ref id="R20"><mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>CL</given-names></name>, <name><surname>Paulose-Ram</surname><given-names>R</given-names></name>, <name><surname>Ogden</surname><given-names>CL</given-names></name>, <name><surname>Carroll</surname><given-names>MD</given-names></name>, <name><surname>Kruszon-Moran</surname><given-names>D</given-names></name>, <name><surname>Dohrmann</surname><given-names>SM</given-names></name>, <etal/>, <year>2013</year>. <article-title>National health and nutrition examination survey: analytic guidelines, 1999&#x02013;2010</article-title>. <source>Vital Health Stat</source>. <volume>2</volume> (<issue>161</issue>), <fpage>1</fpage>&#x02013;<lpage>24</lpage>.</mixed-citation></ref><ref id="R21"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>D</given-names></name>, <name><surname>Li</surname><given-names>AA</given-names></name>, <name><surname>Ahmed</surname><given-names>A</given-names></name>, <year>2018</year>. <article-title>Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis</article-title>. <source>Liver Int</source>. <volume>38</volume> (<issue>10</issue>), <fpage>1839</fpage>&#x02013;<lpage>1848</lpage>.<pub-id pub-id-type="pmid">29797393</pub-id>
</mixed-citation></ref><ref id="R22"><mixed-citation publication-type="journal"><name><surname>Korkiakoski</surname><given-names>A</given-names></name>, <name><surname>K&#x000e4;r&#x000e4;j&#x000e4;m&#x000e4;ki</surname><given-names>AJ</given-names></name>, <name><surname>Ronkainen</surname><given-names>J</given-names></name>, <name><surname>Auvinen</surname><given-names>J</given-names></name>, <name><surname>Hannuksela</surname><given-names>J</given-names></name>, <name><surname>Kes&#x000e4;niemi</surname><given-names>YA</given-names></name>, <etal/>, <year>2022</year>. <article-title>Nonalcoholic fatty liver disease and its prognosis associates with shorter leucocyte telomeres in a 21-year follow-up study</article-title>. <source>Scand J. Clin. Lab Invest</source>. <volume>82</volume> (<issue>3</issue>), <fpage>173</fpage>&#x02013;<lpage>180</lpage>.<pub-id pub-id-type="pmid">35416741</pub-id>
</mixed-citation></ref><ref id="R23"><mixed-citation publication-type="journal"><name><surname>Lauby-Secretan</surname><given-names>B</given-names></name>, <name><surname>Loomis</surname><given-names>D</given-names></name>, <name><surname>Baan</surname><given-names>R</given-names></name>, <name><surname>El Ghissassi</surname><given-names>F</given-names></name>, <name><surname>Bouvard</surname><given-names>V</given-names></name>, <name><surname>Benbrahim-Tallaa</surname><given-names>L</given-names></name>, <etal/>, <year>2016</year>. <article-title>Use of mechanistic data in the IARC evaluations of the carcinogenicity of polychlorinated biphenyls and related compounds</article-title>. <source>Environ. Sci. Pollut. Res. Int</source>. <volume>23</volume> (<issue>3</issue>), <fpage>2220</fpage>&#x02013;<lpage>2229</lpage>.<pub-id pub-id-type="pmid">26077316</pub-id>
</mixed-citation></ref><ref id="R24"><mixed-citation publication-type="journal"><name><surname>Levin</surname><given-names>R</given-names></name>, <name><surname>Zilli Vieira</surname><given-names>CL</given-names></name>, <name><surname>Rosenbaum</surname><given-names>MH</given-names></name>, <name><surname>Bischoff</surname><given-names>K</given-names></name>, <name><surname>Mordarski</surname><given-names>DC</given-names></name>, <name><surname>Brown</surname><given-names>MJ</given-names></name>, <year>2021</year>. <article-title>The urban lead (Pb) burden in humans, animals and the natural environment</article-title>. <source>Environ. Res</source>. <volume>193</volume>, 110377.</mixed-citation></ref><ref id="R25"><mixed-citation publication-type="journal"><name><surname>Loomba</surname><given-names>R</given-names></name>, <name><surname>Adams</surname><given-names>LA</given-names></name>, <year>2020</year>. <article-title>Advances in non-invasive assessment of hepatic fibrosis</article-title>. <source>Gut</source>
<volume>69</volume> (<issue>7</issue>), <fpage>1343</fpage>&#x02013;<lpage>1352</lpage>.<pub-id pub-id-type="pmid">32066623</pub-id>
</mixed-citation></ref><ref id="R26"><mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>N</given-names></name>, <name><surname>Yip</surname><given-names>R</given-names></name>, <name><surname>Lewis</surname><given-names>S</given-names></name>, <name><surname>Dinani</surname><given-names>A</given-names></name>, <name><surname>Wyatt</surname><given-names>C</given-names></name>, <name><surname>Crane</surname><given-names>M</given-names></name>, <etal/>, <year>2023</year>. <article-title>Environmental exposures are important risk factors for advanced liver fibrosis in African American adults</article-title>. <source>JHEP Rep</source>. <volume>5</volume> (<issue>4</issue>), 100696.</mixed-citation></ref><ref id="R27"><mixed-citation publication-type="journal"><name><surname>Ng</surname><given-names>CH</given-names></name>, <name><surname>Lim</surname><given-names>WH</given-names></name>, <name><surname>Hui Lim</surname><given-names>GE</given-names></name>, <name><surname>Hao Tan</surname><given-names>DJ</given-names></name>, <name><surname>Syn</surname><given-names>N</given-names></name>, <name><surname>Muthiah</surname><given-names>MD</given-names></name>, <etal/>, <year>2023</year>. <article-title>Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and meta-analysis</article-title>. <source>Clin. Gastroenterol Hepatol</source>. <volume>21</volume> (<issue>4</issue>), <fpage>931</fpage>&#x02013;<lpage>939.e935</lpage>.<pub-id pub-id-type="pmid">35513235</pub-id>
</mixed-citation></ref><ref id="R28"><mixed-citation publication-type="journal"><name><surname>Niehoff</surname><given-names>NM</given-names></name>, <name><surname>Gammon</surname><given-names>MD</given-names></name>, <name><surname>Keil</surname><given-names>AP</given-names></name>, <name><surname>Nichols</surname><given-names>HB</given-names></name>, <name><surname>Engel</surname><given-names>LS</given-names></name>, <name><surname>Taylor</surname><given-names>JA</given-names></name>, <etal/>, <year>2019</year>. <article-title>Hazardous air pollutants and telomere length in the Sister Study</article-title>. <source>Environ. Epidemiol</source>. <volume>3</volume> (<issue>4</issue>).</mixed-citation></ref><ref id="R29"><mixed-citation publication-type="journal"><name><surname>Othman</surname><given-names>N</given-names></name>, <name><surname>Ismail</surname><given-names>Z</given-names></name>, <name><surname>Selamat</surname><given-names>MI</given-names></name>, <name><surname>Sheikh Abdul Kadir</surname><given-names>SH</given-names></name>, <name><surname>Shibraumalisi</surname><given-names>NA</given-names></name>, <year>2022</year>. <article-title>A review of polychlorinated biphenyls (PCBs) pollution in the air: where and how much are we exposed to?</article-title>
<source>Int. J. Environ. Res. Public Health</source>
<volume>19</volume> (<issue>21</issue>), 13923.</mixed-citation></ref><ref id="R30"><mixed-citation publication-type="journal"><name><surname>Pawlas</surname><given-names>N</given-names></name>, <name><surname>P&#x00142;achetka</surname><given-names>A</given-names></name>, <name><surname>Koz&#x00142;owska</surname><given-names>A</given-names></name>, <name><surname>Broberg</surname><given-names>K</given-names></name>, <name><surname>Kasperczyk</surname><given-names>S</given-names></name>, <year>2015</year>. <article-title>Telomere length in children environmentally exposed to low-to-moderate levels of lead</article-title>. <source>Toxicol. Appl. Pharmacol</source>. <volume>287</volume> (<issue>2</issue>), <fpage>111</fpage>&#x02013;<lpage>118</lpage>.<pub-id pub-id-type="pmid">25981164</pub-id>
</mixed-citation></ref><ref id="R31"><mixed-citation publication-type="journal"><name><surname>Poretz</surname><given-names>RD</given-names></name>, <name><surname>Yang</surname><given-names>A</given-names></name>, <name><surname>Deng</surname><given-names>W</given-names></name>, <name><surname>Manowitz</surname><given-names>P</given-names></name>, <year>2000</year>. <article-title>The interaction of lead exposure and arylsulfatase A genotype affects sulfatide catabolism in human fibroblasts</article-title>. <source>Neurotoxicology</source>
<volume>21</volume> (<issue>3</issue>), <fpage>379</fpage>&#x02013;<lpage>387</lpage>.<pub-id pub-id-type="pmid">10894127</pub-id>
</mixed-citation></ref><ref id="R32"><mixed-citation publication-type="journal"><name><surname>Prosper</surname><given-names>A</given-names></name>, <name><surname>Brown</surname><given-names>K</given-names></name>, <name><surname>Schussel</surname><given-names>B</given-names></name>, <name><surname>Aberle</surname><given-names>D</given-names></name>, <year>2020</year>. <article-title>Lung cancer screening in African Americans: the time to act is now</article-title>. <source>Radiol. Imaging Cancer</source>
<volume>2</volume> (<issue>5</issue>), e200107.</mixed-citation></ref><ref id="R33"><mixed-citation publication-type="journal"><name><surname>Rattan</surname><given-names>P</given-names></name>, <name><surname>Penrice</surname><given-names>DD</given-names></name>, <name><surname>Ahn</surname><given-names>JC</given-names></name>, <name><surname>Ferrer</surname><given-names>A</given-names></name>, <name><surname>Patnaik</surname><given-names>M</given-names></name>, <name><surname>Shah</surname><given-names>VH</given-names></name>, <etal/>, <year>2022</year>. <article-title>Inverse association of telomere length with liver disease and mortality in the US population</article-title>. <source>Hepatol. Commun</source>. <volume>6</volume> (<issue>2</issue>), <fpage>399</fpage>&#x02013;<lpage>410</lpage>.<pub-id pub-id-type="pmid">34558851</pub-id>
</mixed-citation></ref><ref id="R34"><mixed-citation publication-type="journal"><name><surname>Renzetti</surname><given-names>S</given-names></name>, <name><surname>Gennings</surname><given-names>C</given-names></name>, <name><surname>Curtin</surname><given-names>PC</given-names></name>, <year>2019</year>. <article-title>gWQS: an R package for linear and generalized weighted quantile sum (WQS) regression</article-title>. <source>J. Stat. Softw</source>. <fpage>1</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="R35"><mixed-citation publication-type="journal"><name><surname>Shen</surname><given-names>X</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Yan</surname><given-names>X</given-names></name>, <name><surname>Liu</surname><given-names>W</given-names></name>, <name><surname>Guo</surname><given-names>Y</given-names></name>, <etal/>, <year>2019</year>. <article-title>Low-dose PCB126 compromises circadian rhythms associated with disordered glucose and lipid metabolism in mice</article-title>. <source>Environ. Int</source>. <volume>128</volume>, <fpage>146</fpage>&#x02013;<lpage>157</lpage>.<pub-id pub-id-type="pmid">31055201</pub-id>
</mixed-citation></ref><ref id="R36"><mixed-citation publication-type="journal"><name><surname>Sripada</surname><given-names>K</given-names></name>, <name><surname>Lager</surname><given-names>AM</given-names></name>, <year>2022</year>. <article-title>Interventions to reduce cadmium exposure in low- and middle-income countries during pregnancy and childhood: A systematic review</article-title>. <source>J. Glob. Health</source>
<volume>12</volume>, 04089.</mixed-citation></ref><ref id="R37"><mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>JY</given-names></name>, <name><surname>Wright</surname><given-names>ML</given-names></name>, <name><surname>Housman</surname><given-names>D</given-names></name>, <year>2016</year>. <article-title>Lead toxicity and genetics in Flint, MI</article-title>. <source>NPJ Genom. Med</source>. <volume>1</volume> (<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>2</lpage>.</mixed-citation></ref><ref id="R38"><mixed-citation publication-type="journal"><name><surname>Tibshirani</surname><given-names>R</given-names></name>, <year>1996</year>. <article-title>Regression shrinkage and selection via the lasso</article-title>. <source>J. R. Stat. Soc. Series B</source>. <volume>58</volume> (<issue>1</issue>), 267288.</mixed-citation></ref><ref id="R39"><mixed-citation publication-type="journal"><name><surname>Tinkov</surname><given-names>AA</given-names></name>, <name><surname>Aschner</surname><given-names>M</given-names></name>, <name><surname>Santamaria</surname><given-names>A</given-names></name>, <name><surname>Bogdanov</surname><given-names>AR</given-names></name>, <name><surname>Tizabi</surname><given-names>Y</given-names></name>, <name><surname>Virgolini</surname><given-names>MB</given-names></name>, <etal/>, <year>2023</year>. <article-title>Dissecting the role of cadmium, lead, arsenic, and mercury in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis</article-title>. <source>Environ. Res</source>. 117134.</mixed-citation></ref><ref id="R40"><mixed-citation publication-type="journal"><name><surname>Van den Berg</surname><given-names>M</given-names></name>, <name><surname>Birnbaum</surname><given-names>LS</given-names></name>, <name><surname>Denison</surname><given-names>M</given-names></name>, <name><surname>De Vito</surname><given-names>M</given-names></name>, <name><surname>Farland</surname><given-names>W</given-names></name>, <name><surname>Feeley</surname><given-names>M</given-names></name>, <etal/>, <year>2006</year>. <article-title>The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds</article-title>. <source>Toxicol. Sci</source>. <volume>93</volume> (<issue>2</issue>), <fpage>223</fpage>&#x02013;<lpage>241</lpage>.<pub-id pub-id-type="pmid">16829543</pub-id>
</mixed-citation></ref><ref id="R41"><mixed-citation publication-type="journal"><name><surname>van den Berg</surname><given-names>M</given-names></name>, <name><surname>Kypke</surname><given-names>K</given-names></name>, <name><surname>Kotz</surname><given-names>A</given-names></name>, <name><surname>Tritscher</surname><given-names>A</given-names></name>, <name><surname>Lee</surname><given-names>SY</given-names></name>, <name><surname>Magulova</surname><given-names>K</given-names></name>, <etal/>, <year>2017</year>. <article-title>WHO/UNEP global surveys of PCDDs, PCDFs, PCBs and DDTs in human milk and benefit&#x02013;risk evaluation of breastfeeding</article-title>. <source>Arch. Toxicol</source>. <volume>91</volume>, <fpage>83</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">27438348</pub-id>
</mixed-citation></ref><ref id="R42"><mixed-citation publication-type="journal"><name><surname>Wesselink</surname><given-names>AK</given-names></name>, <name><surname>Bethea</surname><given-names>TN</given-names></name>, <name><surname>McClean</surname><given-names>M</given-names></name>, <name><surname>Weuve</surname><given-names>J</given-names></name>, <name><surname>Williams</surname><given-names>PL</given-names></name>, <name><surname>Hauser</surname><given-names>R</given-names></name>, <etal/>, <year>2019</year>. <article-title>Predictors of plasma polychlorinated biphenyl concentrations among reproductive-aged black women</article-title>. <source>Int. J. Hyg. Environ. Health</source>
<volume>222</volume> (<issue>7</issue>), <fpage>1001</fpage>&#x02013;<lpage>1010</lpage>.<pub-id pub-id-type="pmid">31285139</pub-id>
</mixed-citation></ref><ref id="R43"><mixed-citation publication-type="journal"><name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Luo</surname><given-names>X</given-names></name>, <name><surname>Wu</surname><given-names>J</given-names></name>, <year>2022</year>. <article-title>Association between urinary metals and leukocyte telomere length involving an artificial neural network prediction: Findings based on NHANES 1999&#x02013;2002</article-title>. <source>Front. Public Health</source>
<volume>10</volume>, 963138.</mixed-citation></ref><ref id="R44"><mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>YC</given-names></name>, <year>2010</year>. <article-title>Multiple imputation for missing data: Concepts and new development (Version 9.0)</article-title>. <source>SAS Institute Inc. Rockville, MD</source>, <volume>49</volume> (<issue>1&#x02013;11</issue>), <fpage>12</fpage>.</mixed-citation></ref><ref id="R45"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>W</given-names></name>, <name><surname>Sargis</surname><given-names>RM</given-names></name>, <name><surname>Volden</surname><given-names>PA</given-names></name>, <name><surname>Carmean</surname><given-names>CM</given-names></name>, <name><surname>Sun</surname><given-names>XJ</given-names></name>, <name><surname>Brady</surname><given-names>MJ</given-names></name>, <year>2012</year>. <article-title>PCB 126 and other dioxin-like PCBs specifically suppress hepatic PEPCK expression via the aryl hydrocarbon receptor</article-title>. <source>PLoS One</source>
<volume>7</volume> (<issue>5</issue>), e37103.</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Fig. 1</label><caption><p id="P39">Flowcharts showing the five groups of participants. (a) Flowchart of 33,979 adult participants in the National Health and Nutrition Examination Survey (NHANES, 2003&#x02013;2018) included in the analyses of mixtures of toxins. <bold>Group 1</bold>: participants had data on blood levels of cadmium, lead and mercury; <bold>group 2</bold>: a subset of 10,257 adults had data on blood levels of four PFAS (PFOS, PFOA, PFHxS, PFNA); <bold>group 3</bold>: a subset of 12,847 adults had data on urine levels of eight metals (lead, cadmium, barium, cesium, cobalt, antimony, thallium, tungsten); and <bold>group 4</bold>: a subset of 1043 adults had data on blood levels of 34 PCBs and six PCDD/Fs. (b) <bold>Group 5</bold>: flowchart of 7360 adult participants in NHANES 1999&#x02013;2002 with data on telomere length of blood cells and blood levels of cadmium and lead. Abbreviations: PFAS: per- and polyfluoroalkyl substances; PFOS: Perfluorooctane sulfonic acid; PFOA: Perfluorooctanoic acid; PFHxS: Perfluorohexane sulfonic acid; PFNA: Perfluorononanoic acid; PCB: polychlorinated biphenyls; PCDD: polychlorinated dibenzo-p-dioxins (PCDD); and PCD: polychlorinated dibenzofuranes.</p></caption><graphic xlink:href="nihms-2020577-f0001" position="float"/></fig><fig position="float" id="F2"><label>Fig. 2</label><caption><p id="P40">Age-standardized weighted means of blood levels of toxins stratified by race/ethnicity. Age-standardized weighted means of blood levels of (a) lead, Pb; (b) cadmium, Cd; (c) mercury, Hg; (d) PCB126; (e) PCB101; (f) PCB172; (g) PCB151; (h) PCB105; (i) PCB87; (j) PCB118; (k) PCB149; (l) PCB49; (m) HpCDD; (n) OCDD; (o) HxCDF; (p) PeCDF, stratified by race/ethnicity, showing results for the total group (all), non-Hispanic White (NHW, blue), non-Hispanic Black (NHB, red), Mexican American (MA, grey), and other (O, light grey) racial/ethnic groups. Panels a, b, and c were based on the data in group 1, and the rest of panels were based on data in group 4. Differences between groups were tested by univariate t statistic at a significance level of two-sided <italic toggle="yes">P</italic> value &#x0003c; 0.05. Abbreviation: HpCDD: 1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin; OCDD: 1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin; PCB: polychlorinated biphenyls; HxCDF: 1,2,3,4,7,8-Hexachlorodibenzofura; PeCDF:2,3,4,7,8-Pentachlorodibenzofuran; SE: standard error.</p></caption><graphic xlink:href="nihms-2020577-f0002" position="float"/></fig><fig position="float" id="F3"><label>Fig. 3</label><caption><p id="P41">Weights of the components and estimated odds ratios per decile of the WQS<sub>metal</sub> indices with the outcome of advanced liver fibrosis in group 1. Blood levels of metals (lead, cadmium and mercury) were analyzed in weighted quantile sums (WQS) models with the outcome of advanced liver fibrosis (ALT elevation plus FIB-4 &#x02265; 2.67 and/or Forns &#x02265; 6.9 and/or APRI &#x02265; 1.5). By default, metals in the mixture were considered significant if their weights exceeded the inverse of the number of elements in the mixture, which is 1/3 (0.333), indicated by the red dashed line. Weights and the estimated odds ratios (OR) per decile of the WQS<sub>metal</sub> indices are reported for the total population. (a) total; (b) Non-Hispanic White, (NHW); (c) Non-Hispanic Black (NHB); (d) Mexican American (MA); (e) other racial/ethnic group. Weights of lead are colored green. Data of blood levels of cadmium, lead and mercury were not normally distributed and were log-transformed in the analysis.</p></caption><graphic xlink:href="nihms-2020577-f0003" position="float"/></fig><fig position="float" id="F4"><label>Fig. 4</label><caption><p id="P42">Weights of significant components in the WQS<sub>metal-PCB/PCDD/F</sub> index (a) and ORs by decile of WQS indices with the outcome of ALT elevation (b and c). (a) Bar plot showing the weights of significant components in the WQS<sub>metal-PCB/PCDD/F</sub> index. The significant components exceed to the inverse of the number of elements in the mixture, which was 1/42 = 0.024, red dash line. Components with weights over 0.005 may be significant contributors (horizontal dash black line). Non-significant components were not plotted. (b) Graph of group 2 data (which include blood metals and PFAS) showing the ORs of the WQS indices by decile for the outcome of ALT elevation after adjusting for age, sex, and race/ethnicity; (c) graph of group 4 data (which include blood metals and PCBs) showing the ORs of the WQS indices by decile for the outcome of ALT elevation after adjusted with age, sex, and race/ethnicity. Limited by the sample size, the covariates included only age, sex, and race/ethnicity. Abbreviations: ALT: alanine aminotransferase; Cd: cadmium; Pb: lead; Hg: Mercury; OR: odds ratio; PFAS; per- and polyfluoroalkyl substances; PCB: polychlorinated biphenyls; PCDD: polychlorinated dibenzo-p-dioxins; PCDF: polychlorinated dibenzofurans; PFOA: Perfluorooctanoic acid; PFNA: Perfluorononanoic acid; WQS: Weighted Quantile Sums.</p></caption><graphic xlink:href="nihms-2020577-f0004" position="float"/></fig><fig position="float" id="F5"><label>Fig. 5</label><caption><p id="P43">MVL analysis of the relationship between telomere length and advanced fibrosis (a) and analysis of the relationship between the WQS metal index and short telomeres (b). (a) Plot of the ORs from MVL models analyzing the relationship between telomere length by quartile [reference was Q4 telomere] and advanced fibrosis adjusted for age, sex, diabetes, body mass index, alcohol use, smoking status, and poverty. (b) WQS models analyzing the relationship between WQS indices of blood levels of lead (Pb) and cadmium (Cd) and short (Q1) telomeres, with adjustment for age, sex, smoking status, alcohol use, body mass index and diabetes. Bar graphs indicate the weights of significant contributors (indicated by the red dotted line) in the total population and in individual racial/ethnic groups. By default, metals were considered significant if their weights exceeded the inverse of the number of elements in the mixture, which is 1/2 (0.5), indicated by a red dotted line. ORs are per decile of WQS index scores. Data of blood levels of cadmium and lead were not normally distributed and were log-transformed in the analysis. Abbreviations: MVL: multivariable logistic regression; OR: odds ratio; Q: quartile; WQS: Weighted Quantile Sums.</p></caption><graphic xlink:href="nihms-2020577-f0005" position="float"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p id="P44">Odds ratios from multivariable logistic regression models with the outcome of advanced liver fibrosis with blood levels of three metals included as independent variables (Q1&#x02013;3 and Q4) with stratification by race/ethnicity</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Cohorts</th><th colspan="5" align="center" valign="top" rowspan="1">OR (95% CI)</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">Sample size (<italic toggle="yes">n</italic>)</th><th align="center" valign="top" rowspan="1" colspan="1">Total (33,979)</th><th align="center" valign="top" rowspan="1" colspan="1">NHW (15,091)</th><th align="center" valign="top" rowspan="1" colspan="1">NHB (7046)</th><th align="center" valign="top" rowspan="1" colspan="1">MA (5532)</th><th align="center" valign="top" rowspan="1" colspan="1">O (6310)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>&#x02003;Advanced fibrosis (weighted %)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>496 (1.19)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>207 (1.19)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>118 (1.41)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>90 (1.38)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>81 (0.87)</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&#x02003;Survey Cycle</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.09</bold>
<break/><bold>(1.04, 1.15)</bold>
<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="left" valign="top" rowspan="1" colspan="1"><bold>1.12</bold>
<break/><bold>(1.05, 1.20)</bold>
<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1.01 <break/>(0.93, 1.10)</td><td align="center" valign="top" rowspan="1" colspan="1">1.08 <break/>(0.96, 1.22)</td><td align="center" valign="top" rowspan="1" colspan="1">1.04 <break/>(0.90, 1.21)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&#x02003;Age (per 10 years)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.44</bold>
<break/><bold>(1.33, 1.57)</bold>
<xref rid="TFN4" ref-type="table-fn">&#x02021;</xref></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.39</bold>
<break/><bold>(1.23, 1.57)</bold>
<xref rid="TFN4" ref-type="table-fn">&#x02021;</xref></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.40</bold>
<break/><bold>(1.21, 1.63)</bold>
<xref rid="TFN4" ref-type="table-fn">&#x02021;</xref></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.55</bold>
<break/><bold>(1.27, 1.89)</bold>
<xref rid="TFN4" ref-type="table-fn">&#x02021;</xref></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.93</bold>
<break/><bold>(1.67, 2.23)</bold>
<xref rid="TFN4" ref-type="table-fn">&#x02021;</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>&#x02003;Gender</bold>
</td><td colspan="5" align="center" valign="top" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female</td><td colspan="5" align="center" valign="top" rowspan="1">Reference</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.62</bold>
<break/><bold>(1.21, 2.18)</bold>
<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.68</bold>
<break/><bold>(1.11, 2.56)</bold>
<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1.51 <break/> (0.94, 2.44)</td><td align="center" valign="top" rowspan="1" colspan="1">1.61 <break/>(0.87, 3.01)</td><td align="center" valign="top" rowspan="1" colspan="1">1.40 <break/>(0.75, 2.62)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Diabetes</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td colspan="5" align="center" valign="top" rowspan="1">Reference</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Yes</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.60</bold>
<break/><bold>(2.00, 3.38)</bold>
<xref rid="TFN4" ref-type="table-fn">&#x02021;</xref></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>3.12</bold>
<break/><bold>(2.18, 4.47)</bold>
<xref rid="TFN4" ref-type="table-fn">&#x02021;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.73 <break/>(0.46, 1.17)</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.12</bold>
<break/><bold>(1.19, 3.79)</bold>
<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>3.11</bold>
<break/><bold>(1.66, 5.80)</bold>
<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>BMI</bold>
</td><td colspan="5" align="center" valign="top" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Normal</td><td colspan="5" align="center" valign="top" rowspan="1">Reference</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Overweight</td><td align="center" valign="top" rowspan="1" colspan="1">0.94 <break/>(0.63, 1.42)</td><td align="center" valign="top" rowspan="1" colspan="1">0.87 <break/>(0.49, 1.54)</td><td align="center" valign="top" rowspan="1" colspan="1">1.21 <break/>(0.68, 2.16)</td><td align="center" valign="top" rowspan="1" colspan="1">1.16 <break/>(0.55, 2.44)</td><td align="center" valign="top" rowspan="1" colspan="1">0.89 <break/>(0.42, 1.88)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Obese</td><td align="center" valign="top" rowspan="1" colspan="1">1.02 <break/>(0.72, 1.43)</td><td align="center" valign="top" rowspan="1" colspan="1">0.90 <break/>(0.56, 1.44)</td><td align="center" valign="top" rowspan="1" colspan="1">1.02 <break/>(0.56, 1.86)</td><td align="center" valign="top" rowspan="1" colspan="1">1.19 <break/>(0.56, 2.52)</td><td align="center" valign="top" rowspan="1" colspan="1">1.68 <break/>(0.78, 3.63)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Alcohol use</bold>
</td><td colspan="5" align="center" valign="top" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lifetime abstainers</td><td colspan="5" align="center" valign="top" rowspan="1">Reference</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Former drinkers</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 <break/>(0.61, 1.53)</td><td align="center" valign="top" rowspan="1" colspan="1">0.74 <break/>(0.38, 1.42)</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.58</bold>
<break/><bold>(1.08, 6.18)</bold>
<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.71 <break/>(0.25, 2.01)</td><td align="center" valign="top" rowspan="1" colspan="1">1.53 <break/>(0.67, 3.47)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Non-excessive current drinkers</td><td align="center" valign="top" rowspan="1" colspan="1">1.08 <break/>(0.70, 1.67)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 <break/>(0.54, 1.87)</td><td align="center" valign="top" rowspan="1" colspan="1">1.83 <break/>(0.71, 4.75)</td><td align="center" valign="top" rowspan="1" colspan="1">0.82 <break/>(0.25, 2.65)</td><td align="center" valign="top" rowspan="1" colspan="1">1.05 <break/>(0.42, 2.63)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Excessive current drinkers</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.13</bold><break/><bold>(1.32, 3.44)</bold>
<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1.86 <break/>(0.90, 3.83)</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>3.06</bold>
<break/><bold>(1.24, 7.58)</bold>
<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1.97 <break/>(0.62, 6.22)</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.79</bold>
<break/><bold>(1.02, 7.65)</bold>
<xref rid="TFN2" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Smoking status</bold>
</td><td colspan="5" align="center" valign="top" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Never</td><td colspan="5" align="center" valign="top" rowspan="1">Reference</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Past/current</td><td align="center" valign="top" rowspan="1" colspan="1">1.30 <break/>(0.95, 1.80)</td><td align="center" valign="top" rowspan="1" colspan="1">1.43 <break/>(0.90, 2.29)</td><td align="center" valign="top" rowspan="1" colspan="1">0.99 <break/>(0.59, 1.68)</td><td align="center" valign="top" rowspan="1" colspan="1">1.37 <break/>(0.71, 2.64)</td><td align="center" valign="top" rowspan="1" colspan="1">0.98 <break/>(0.48, 2.02)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Poverty</bold>
</td><td colspan="5" align="center" valign="top" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td colspan="5" align="center" valign="top" rowspan="1">Reference</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Yes</td><td align="center" valign="top" rowspan="1" colspan="1">1.18 <break/>(0.89, 1.56)</td><td align="center" valign="top" rowspan="1" colspan="1">0.93 <break/>(0.58, 1.48)</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.12</bold>
<break/><bold>(1.35, 3.34)</bold>
<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.98 <break/>(0.52, 1.84)</td><td align="center" valign="top" rowspan="1" colspan="1">0.92 <break/>(0.46, 1.83)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Blood Lead (Pb)</bold>
</td><td colspan="5" align="center" valign="top" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q1&#x02013;3</td><td colspan="5" align="center" valign="top" rowspan="1">Reference</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Q4</td><td align="center" valign="middle" rowspan="1" colspan="1">1.24 (0.89, 1.73)</td><td align="center" valign="top" rowspan="1" colspan="1">1.19 <break/>(0.75, 1.90)</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.26</bold>
<break/><bold>(1.37, 3.74)</bold>
<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.71 <break/>(0.37, 1.39)</td><td align="center" valign="top" rowspan="1" colspan="1">1.12 <break/>(0.59, 2.11)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Blood Cadmium</bold>
<break/><bold>(Cd)</bold></td><td colspan="5" align="center" valign="middle" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q1&#x02013;3</td><td colspan="5" align="center" valign="top" rowspan="1">Reference</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Q4</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.01</bold>
<break/><bold>(1.45, 2.78)</bold>
<xref rid="TFN4" ref-type="table-fn">&#x02021;</xref></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.07</bold>
<break/><bold>(1.27, 3.36)</bold>
<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.73</bold>
<break/><bold>(1.04, 2.86)</bold>
<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.08</bold>
<break/><bold>(1.13, 3.82)</bold>
<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.19</bold>
<break/><bold>(1.18, 4.08)</bold>
<xref rid="TFN2" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Blood Mercury (Hg)</bold>
</td><td colspan="5" align="center" valign="middle" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q1&#x02013;3</td><td colspan="5" align="center" valign="top" rowspan="1">Reference</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Q4</td><td align="center" valign="top" rowspan="1" colspan="1">0.80 <break/>(0.58, 1.12)</td><td align="center" valign="top" rowspan="1" colspan="1">0.86 <break/>(0.53, 1.40)</td><td align="center" valign="top" rowspan="1" colspan="1">1.01 <break/>(0.60, 1.71)</td><td align="center" valign="top" rowspan="1" colspan="1">0.54 <break/>(0.25, 1.16)</td><td align="center" valign="top" rowspan="1" colspan="1">0.68 <break/>(0.40, 1.17)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P45">Multiple imputation was performed in multivariate logistic regression models.</p></fn><fn id="TFN2"><label>*</label><p id="P46"><italic toggle="yes">P</italic> &#x0003c; .05,</p></fn><fn id="TFN3"><label>&#x02020;</label><p id="P47"><italic toggle="yes">P</italic> &#x0003c; .001,</p></fn><fn id="TFN4"><label>&#x02021;</label><p id="P48"><italic toggle="yes">P</italic> &#x0003c; .0001. Advanced fibrosis was defined as ALT elevation and APRI &#x02265;1.5 and/or FIB-4 &#x02265;2.67 and/or Forns &#x02265;6.9. Abbreviations: ALT: alanine aminotransferase; APRI: Aspartate aminotransferase to platelet ratio index; FIB-4: Fibrosis-4; OR: odds ratio; CI: confidence interval; BMI: body mass index; NHW: Non-Hispanic White; NHB: Non-Hispanic Black; MA: Mexican American; O: other race; Q: quartile.</p></fn></table-wrap-foot></table-wrap></floats-group></article>